Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells

Cancer Research

Volumn 57, Issue 21, 1997, Pages 4931-4939

  Sun, Shi Yong ^a   Yue, Ping ^a   Dawson, Marcia I ^b   Shroot, Braham ^c   Michel, Serge ^c   Lamph, William W ^d   Heyman, Richard A ^d   Teng, Min ^e   Chandraratna, Roshantha A S ^e   Shudo, Koichi ^f   Hong, Waun K ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SRI INTERNATIONAL   (United States)

^c Ctr Internationale Rech D   (France)

^d LIGAND PHARMACEUTICALS INC   (United States)

^e ALLERGAN INC   (United States)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DI TERT BUTYL 4' CHALCONECARBOXYLIC ACID; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ADAPALENE; CD 2325; CELL NUCLEUS RECEPTOR; CELLULAR RETINOL BINDING PROTEIN; CLOTRIMAZOLE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; SR 11364; TD 550; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CELL GROWTH; DRUG POTENCY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; TRANSACTIVATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0030731915     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer Statistics, 1997. CA Cancer J. Clin., 47: 5-27, 1997.
2. Smith, M. A., Parkinson, D. R., Cheson, B. D., and Friedman, M. A. Retinoids in cancer therapy. J. Clin. Oncol., 10: 839-864, 1992.
3. Benner, S. E., Lippman, S. M., and Hong, W. K. Current status of retinoid chemoprevention of lung Cancer. Oncology, 9: 205-210, 1995.
4. Hong, W. K., and Itri, L. M. Retinoids and human cancer. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 597-658. New York: Raven Press, 1994.
5. Pastorino, U., Infante, M., Maioli, M., Chiesa, G., Buyse, M., Pirket, P., Rosmentz, N., Clerici, M., Soresi, E., Valente, M., Belloni, P., and Ravasi, G. Adjuvant treatment of stage I lung cancer with high dose vitamin A. J. Clin. Oncol., 11: 1216-1222, 1993.
6. Gudas, L. J., Sporn, M. B., and Roberts, A. B. Cellular biology and biochemistry of the retinoids. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 443-520. New York: Raven Press, 1994.
7. Lotan, R. Cellular biology of the retinoids. In: L. Degos and D. R. Parkinson (eds.), Retinoids in Oncology, pp. 27-42. Berlin: Springer-Verlag, 1995.
8. Wu, R., Martin, W., Robinson, C., St. George, J., Plopper, C., Kurlan, G., Last, J., Cross, C., McDonald, R., and Boucher, R. Expression of mucin synthesis and secretion in human tracheobronchial epithelial cells grown in culture. Am. J. Respir. Cell Mol. Biol., 3: 467-478, 1990.
9. Jetten, A. M., Nervi, C., and Vollberg, T. M. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids. J. Natl. Cancer Inst. Monogr., 13: 93-100, 1992.
10. Saffiotti, U., Montesano, R., Sellakumar, A., and Borg, S. Experimental cancer of the lung: inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumors. Cancer (Phila.), 20: 857-864, 1967.
11. Moon, R. C., Mehta, R. G., and Rao, K. J. V. N. Retinoids and cancer in experimental animals. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 573-595. New York: Raven Press, 1994.
12. Pfahl, M. Vertebrate receptors: molecular biology, dimerization and response elements. Semin. Cell. Biol., 5: 95-103, 1994.
13. Mangelsdorf, D. J., and Evans, R. M. The RXR heterodimers and orphan receptors. Cell, 83: 841-850, 1995.
14. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J., 10: 940-954, 1996.
15. Ong, D. E., Newcomer, M. E., and Chytil, F. Cellular retinoid-binding proteins. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 283-317. New York: Raven Press, 1994.
16. Boylan, J. F., and Gudas, L. J. Overexpression of the cellular retinoic acid binding protein-1 (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J. Cell Biol., 112: 965-979, 1991.
17. Boylan, J. F., and Gudas, L. J. The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. J. Biol. Chem., 267: 21486-21491, 1992.
18. Ng, K. W., Zhow, H., Manji, S., and Martin T J. Regulation and regulatory role of retinoids. Crit. Rev. Eukaryotic Gene Expr., 5: 219-253, 1995.
19. Delescluse, C., Cavey, M. T., Martin, B., Bernard, B. A., Reichert, U., Maignan, J., Darmon, M., and Shroot, B. Selective high affinity retinoic acid receptor α or β-γ ligands. Mol. Pharmacol., 40: 556-562, 1991.
20. Lehmann, J. M., Dawson, M. I., Hobbs, P. D., Husmann, M., and Pfahl, M. Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res., 51: 4804-4809, 1991.
21. Lehmann, J. M., Jong, L., Fanjul, A., Cameron, J. F., Lu, X. P., Haefner, P., Dawson, M. I., and Pfahl, M. Retinoids selective for retinoid X receptor response pathways. Science (Washington DC), 258: 1944-1946, 1992.
22. Apfel, C., Crettaz, M., and LeMotte, P. Differential binding and activation of synthetic retinoids to retinoic acid receptors. In: G. Morriss-Kay (ed.), Retinoids in Normal Development and Teratogenesis, pp. 65-74. Oxford, United Kingdom: Oxford University Press, 1992.
23. Bernard, B. A., Bernardon, J-M., Delescluse, C., Martin, B., Lenoir, M-C, Maignan, J., Charpentier, B., Pilgrim, W. R., Reichert, U., and Shroot, B. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem. Biophys. Res. Commun., 186: 977-983, 1992.
24. Dawson, M. I., Hobbs, P. D., Stein, R. B., Berger, T. S., and Heyman, R. A. Interaction of retinoids with retinoic acid nuclear receptor isoforms. In: M. A. Livrea and L. Packer (eds.), Retinoids: Progress in Research and Clinical Applications, pp. 205-222. New York: Marcel Dekker, Inc., 1992.
25. Keidel, S., Szardenings, M., and Mueller, W. H. In vivo biological activity of retinoids partially correlates to their affinity to recombinant retinoic acid receptor α and recombinant-cellular retinoic acid-binding protein I. Eur. J. Biochem., 212: 13-26, 1993.
26. Boehm, M. F., Zhang, L., Badea, B. A., White, S. K., Mais, D. E., Berger, E., Suto, C. M., Goldman, M. E., and Heyman, R. A. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J. Med. Chem., 37: 2930-2941, 1994.
27. Fanjul, A., Dawson, M. I., Hobbs, P. D., Jong, L., Cameron, J. F., Harlev, E., Graupner, G., Lu, X-P., and Pfahl, M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (Lond.), 372: 107-110, 1994.
28. Dawson, M. I., Jong, L., Hobbs, P. D., Cameron, J. F., Chao, W-R., Pfahl, M., Lee, M-O., Shroot, B,., and Pfahl, M. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J. Med. Chem., 38: 3368-3383, 1995.
29. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene, 11: 493-504, 1995.
30. Charpentier, B., Bernardon, J-M., Eustache, J., Millois, C., Martin, B., Michel, S., and Shroot, B. Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. J. Med. Chem., 38: 4993-5006, 1995.
31. Kagechika, H., Kawachi, H., Hashimoto, Y., and Shudo, K. Retinobenzoic acids. 2. Structure-activity relationships of chalcone-4-carboxylic acids and flavone-4′-carboxylic acids. J. Med. Chem., 32: 834-840, 1989.
32. Kaneko, S., Kagechika, H., Kawachi, E., Hashimoto, Y., and Shudo, K. Retinoid antagonists. Med. Chem. Res., 1: 220-225, 1991.
33. Shudo, K., and Kagechika, H. Structural evolution of retinoids. Adv. Drug Res., 24: 81-119, 1993.
34. Eyrolles, L., Kagechika, H., Kawachi, E., Fukasawa, H., Iijima, T., Matsushima, Y., Hashimoto, Y., and Shudo, K. Retinobenzoic acids. 6. Retinoids antagonists with a heterocyclic ring. J. Med. Chem., 37: 1508-1517, 1994.
35. Chandraratna, R. A. S., and Weinkam, R. J. Tetralin esters of phenols or benzoic acids having retinoid like activity. U. S. Patent No. 5,231,113, 1993.
36. Chandraratna, R. A. S. Acetylenes disubstituted with a phenyl or heteroaryl group and 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like biological activity. U. S. Patent No. 5,399,561, 1995.
37. Johnson, A. T., Klein, E. S., Gillett, S. J., Wang, L., Song, T. K., Pino, M. E., and Chandraratna, R. A. S. Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. J. Med. Chem., 38: 4764-4767, 1996.
38. Johnson, A. T., Klein, E. S., Wang, L., Pino, M. E., and Chandraratna, R. A. S. Identification of a retinoic acid receptor β subtype specific agonist. J. Med. Chem., 39: 5027-5030, 1997.
39. Beard, R. L. Acetylenes disubstituted with a 5-substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity. U. S. Patent Application Serial No. 08/366,183, 1995.
40. Teng, M. Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity. U. S. Patent Application Serial No. 08/562,000, 1996.
41. Kim, Y-H., Dohi, D. F., Han, G. R., Zou, C-P., Oridate, N., Walsh., G. L., Nesbitt, J. C., Xu. X-C., Hong, W. K., Lotan, R., and Kurie, J. M. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Res., 55: 5603-5610, 1995.
42. Geradts, J., Chen, J-Y., Russell, E. K., Yankaskas, J. R., Nieves, L., and Minna, J. D. Human lung cancer cells exhibit resistance to retinoic acid treatment. Cell Growth Differ., 4: 799-809, 1993.
43. Zhang, X. K., Liu, Y., Lee, M-O., and Pfahl, M. A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res., 54: 5663-5669, 1994.
44. Phelps, R. M., Johson, B. E., Ihde, D. C., Gazdar, A. F., Carbone, D. P., McClintock, P. R., Linnoila, I. L., Mattews, M. J., Bunn, P. A., Jr., Carney, D., Minna, J. D, and Mulshine, J. L. NCI-Navy medical oncology branch cell line data base. J. Cell. Biochem., Suppl. 24: 32-91, 1996.
45. Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paul, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., Gray-Goodrich, M., Campbell, H., Mayo, J., and Boyd, M. R. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst., 83: 757-766, 1991.
46. Petkovitch, M., Brand, N. J., Krust, A., and Chambon, P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (Lond.), 330: 444-450, 1987.
47. Brand, N. Petkovitch, M., Krust, A., Chambon, P. The, H. D., Marchio, M., Tiollais, P., and Dejean, A. Identification of a second human retinoic acid receptor. Nature (Lond.), 332: 850-853, 1988.
48. Krust, A., Kastner, P., Petkovitch, M., Zelent, A., and Chambon, P. A third human retinoic acid receptor, hRAR-γ. Proc. Natl. Acad. Sci. USA, 86: 5310-5314, 1989.
49. Mangelsdorf, D. J., Borgmeyer, U., Heyman, R., Zhou, J. Y., Ong, E. S., Oro, A. E., Kakizuka, A., and Evans, R. M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev., 6: 329-344, 1992.
50. Giguere, V., Lyn, S., Yip, P., Siu, C. H., and Amin, S. Molecular cloning of cDNA encoding a second cellular retinoic acid-binding protein. Proc. Natl. Acad. Sci. USA, 87: 6233-6237, 1990.
51. MacGregor, T. M., Copeland, N. G., Jenkins, N. A., and Giguere, V. The murinc gene for cellular retinoic acid-binding protein type II. J. Biol. Chem., 267: 7777-7783, 1992.
52. Dugaiczyk, A., Haron, J. A., Stone, E. M., Dennison, O. E., Rothblum, K. N., and Swartz, R. J. Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger rihonucleic acid isolated from chicken muscle. Biochemistry, 22: 1605-1613, 1983.
53. Carney, D. N., and De Leij, L. Lung cancer biology. Semin. Oncol., 15: 199-214, 1988.
54. Chen, J-Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J. E., Reczek, P., Chambon, P., and Gronemeyer, H. RAR-specific agonist/antagonists which dissociate transactivation and API transrepression inhibit anchorage-independent cell proliferation. EMBO J., 14: 1187-1197, 1995.
55. Dawson, M. I., Elstner, E., Kizaki, M., Chen, D-L., Pakkala, S., Kerner, B., and Koeffler, H. P. Myeloid differentiation mediated through retinoic acid receptor/ retinoid X receptor (RXR) not RXR/RXR pathway. Blood, 84: 446-452, 1994.
56. Kizak, M., Ueno, H., Yamazoe Y., Shimada M., Takayama, N., Muto, A., Matsushita H., Nakajima H., Morikawa M., Koeffler H. P., and Ikeda Y. Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P glycoprotein. Blood, 87: 725-733, 1996.
57. Sheets, J. J., Mason, J. I., Wise, C. A., and Estabrook, R. W. inhibition of rat liver microsomal cytochrome P-450 steroid hydroxylase reactions by imidazole antimycotic agents. Biochem. Pharmcol., 35: 487-491, 1986.
58. Arvelo, F., Poupon, M. F., Bichat, F., Grossin, F., Bourgeois, Y., Jacrot, M., Bastian, G., and Le Chevalier, T. Adding a reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts. Eur. J. Cancer, 31A: 1862-1868, 1995.
59. Masuyama, H., Hiramatsu, Y., and Kudo, T. Effect of retinoids on fetal lung development in the rat. Biol. Neonat., 67: 264-273, 1995.
60. Zachman, R. D. Role of vitamin A in lung development. J. Nutr., 125(Suppl. S): S1634-S1638, 1995.
61. McDowell, E. M., Ben, T., Coleman, B., Chang, S., Newkirk, C., and De Luca, L. M. Effects of retinoic acid on the growth and morphology of hamster tracheal epithelial cells in primary culture. Virchows Arch. B Cell Pathol., 54: 38-51, 1987.
62. Edmondson, S. W., Wu, R., and Mossman, B. T. Regulation of differentiation and keratin protein expression by vitamin A in primary cultures of hamster tracheal epithelial cells. J. Cell. Physiol., 142: 21-30, 1990.
63. Jetten, A. M. Growth and differentiation factors in tracheobronchial epithelium. Am. J. Physiol., 260: L361-L373, 1991.
64. Fitzgerald, D. J., Barrett, J. C., and Nettesheim, P. Changing responsiveness to all-trans retinoic acid of rat tracheal epithelial cells at different stages of neoplastic transformation. Carcinogenesis (Lond.), 7: 1715-1721, 1986.
65. Denning, M. F., and Verma, A. K. Involvement of retinoic acid nuclear receptors in retinoic acid-induced tissue transglutaminase gene expression in rat tracheal 2C5 cells. Biochem. Biophys. Res. Commun., 175: 344-350, 1991.
66. Ahn, M. J., Langenfeld, J., Moasser, M. M., Rusch, V., and Dmitrovsky, E. Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors. Oncogene, 11: 2357-2364, 1995.
67. Gebert, J. F., Moghal, N., Frangioni, J. V., Sugarbaker, D. J., and Neel, B. G. High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene, 6: 1859-1868, 1991.
68. Houle, B., Leduc, F. and Bradley, W. E. Implication of RARβ in epidermoid (squamous) lung cancer. Genes Chromosomes Cancer, 3: 358-366, 1991.
69. Nervi, C., Vollberg, T. M., George, M. D., Chambon, P., and Jetten, A. M. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp. Cell Res., 195: 163-170, 1991.
70. Moghal, N., and Neel, B. G. Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol. Cell. Biol., 15: 3945-3959, 1995.
71. Lotan, R., Dawson, M. I., Zou, C. C., Jong, L., Lotan, D., and Zou, C-P. Enhanced efficacy of combinations of retinoic acid-and retinoid X receptor-selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res., 55: 232-236, 1995.
72. Sheikh, M. S., Shao, Z. M., Li, X-S., Dawson, M. I., Jetten, A. M., Wu, S., Conley, B. A., Garcia, M., Rochefort, H., and Fontana, J. A. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor α acquire sensitivity to growth inhibition by retinoids. J. Biol. Chem., 269: 21440-21447, 1994.
73. Roy, B., Taneja, R., and Chambon, P. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α (RARα)-, RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol. Cell. Biol., 15: 6481-6487, 1995.
74. Schadendorf, D., Kern, M. A., Artuc, M., Pahl, H. L., Rosenbach, T., Fichtner, I., Nurnberg, W., Stuting, S., Stebut, E. V., Worm, M., Makki, A., Jurgovsky, K., Kolde, G., and Henz, B. M. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J. Cell Biol., 135: 1889-1898, 1996.
75. Oridate, N., Higuchi, M., Suzuki, S., Shroot, B., Hong, W. K., and Lotan, R. Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6-[3-(1-adamantyl)hydroxyphenyl]-2-naphthalene carboxylic acid (CD437). Int. J. Cancer, 70: 484-487, 1997.
76. Sun, S-Y., Yue, P., Shroot, B., Hong, W. K., and Lotan, R. Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437. J. Cell. Physiol., in press, 1997.
77. Jetten, A. M., Anderson, K., Deas, M. A., Kagechika, H., Lotan, R., Rearick, J. I., and Shudo, K. New benzoic acid derivatives with retinoid activity: lack of direct correlation between biological activity and binding to CRABP. Cancer Res., 47: 3523-3527, 1987.
78. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
79. Pfahl, M. Nuclear receptor/AP-1 interaction. Endocrinol. Rev., 14: 651-658, 1992.
80. Oridate, N., Esumi, N., Lotan, D., Hong, W. K., Rochette-Egly, C., Chambon, P., and Lotan, R. Implication of retinoic acid receptor γ in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells. Oncogene, 12: 2019-2028, 1996.
81. Nelson, D. R., Kamataki, T., Waxman, D. J., Guengerich, F. P., Estabrook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I. C., Gotoh, O., Okuda, K., and Nebert, D. W. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol., 12: 1-51, 1993.
82. Hamada, H., and Tsuruo, T. Functional role for the 170-and 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 83: 7785-7789, 1986.
83. Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C., and Brown, M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science (Washington DC), 264: 1455-1458, 1994.
84. Chen, D. J., and Evans, R. M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (Lond.), 377: 454-457, 1995.
85. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S-C., Heyman, R. A., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell, 85: 403-414, 1996.